Global Radiation Oncology
Global Radiation Oncology

Radiation Oncology Comprehensive Study by Type (External Beam Radiation Therapy, Brachytherapy, Systemic Beam Radiation Therapy, Others), Application (Blood Cancer (Leukaemia), Breast Cancer, Gastrointestinal Cancer, Respiratory/Lung Cancer, Skin Cancer, Other), Technology (Image-Guided Radiation Therapy (IGRT), Intensity-Modulated Radiation Therapy (IMRT), High Dose Rate (HDR) Brachytherapy, Low Dose Rate (LDR) Brachytherapy, Others), End User (Hospitals, Clinics, Others) Players and Region - Global Market Outlook to 2024

Radiation Oncology Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024  

Jul 2019 Edition 212 Pages 200 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Radiation Oncology Market Overview:
Radiation oncology is a medical specialty which includes the controlled use of radiation to treat cancer either to reduce pain or for treatment and other symptoms caused by cancer. A radiation therapy also known as radiotherapy is the term used to define the actual treatment delivered by the radiation oncology team. Radiation therapy can be applied safely to an extensive range of cancers and may be used alone or in combination with surgery, chemotherapy and other treatments. Furthermore, it is completely non-invasive and accessed through out-patient clinics. Some of the key players profiled in the study are Varian Medical Systems (United States), Elekta AB (Sweden), Accuray Incorporated (United States), Ion Beam Applications SA (Belgium), C.R. Bard, Inc. (United States), Isoray Medical, Inc. (United States), Mevion Medical Systems, Inc. (United States), Nordian Inc. (Canada), NTP Radioisotopes (South Africa) and eviCore (United States).

On the basis of geography, the market of Radiation Oncology has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Technology, the sub-segment i.e. Image-Guided Radiation Therapy (IGRT) will boost the Radiation Oncology market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Hospitals will boost the Radiation Oncology market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Growing Incidence of Cancer Worldwide
  • Growing Elderly Population across the Globe

Market Trend
  • Advancement in Technology of Radiation Oncology

Restraints
  • High Cost Related To Instrument and Therapy

Opportunities
  • Increasing Adoption of Non-Invasive Procedures in Emerging Economies

Challenges
  • Lack of Trained Specialists in Developing Countries


On April 16, 2019 - Isoray, Inc., a medical technology company and innovator in brachytherapy powering expanding treatment options throughout the body, has announced a new training collaboration with Texas Oncology. The collaboration brings together the innovators in internal radiation therapy (brachytherapy) to develop a program focused on training the next generation of brachytherapists. and On January 28, 2019 - Accuray Asia Limited, a subsidiary of Accuray Incorporated, and CNNC High Energy Equipment (Tianjin) Co., Ltd, a subsidiary of China Isotope and Radiation Corporation, has announced the formation of a joint venture to manufacture and sell radiation oncology systems in China.


Target Audience:
Radiation Oncology Therapy Providers, Manufacturers of Medical Devices, Suppliers of Raw Materials, Healthcare Industry, Governmental Bodies and Research Firms

Major Objectives Focused through this Study
• To define, describe, and forecast the Global Radiation Oncology market on the basis of product [External Beam Radiation Therapy, Brachytherapy, Systemic Beam Radiation Therapy and Others] , application [Blood Cancer (Leukaemia), Breast Cancer, Gastrointestinal Cancer, Respiratory/Lung Cancer, Skin Cancer and Other], key regions and end user
• To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
• To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
• Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
• To provide market size for various segments of the Radiation Oncology market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
• To strategically profile the key players and analyzing their market shares and core competencies in the Radiation Oncology industry
• To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are CIVCO Radiotherapy (United States) and Bionix Radiation Therapy (United States).
** Confirmation on availability of data would be informed prior purchase

While framing the research framework, major and emerging players operating in the Radiation Oncology market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Dow Jones (Factiva), along with primary respondents. The complete methodology includes the study of the annual and financial reports of the key market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) related to the market.
Report Objectives / Segmentation Covered
By Type
  • External Beam Radiation Therapy
  • Brachytherapy
  • Systemic Beam Radiation Therapy
  • Others
By Application
  • Blood Cancer (Leukaemia)
  • Breast Cancer
  • Gastrointestinal Cancer
  • Respiratory/Lung Cancer
  • Skin Cancer
  • Other
By Technology
  • Image-Guided Radiation Therapy (IGRT)
  • Intensity-Modulated Radiation Therapy (IMRT)
  • High Dose Rate (HDR) Brachytherapy
  • Low Dose Rate (LDR) Brachytherapy
  • Others

By End User
  • Hospitals
  • Clinics
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Incidence of Cancer Worldwide
      • 3.2.2. Growing Elderly Population across the Globe
    • 3.3. Market Challenges
      • 3.3.1. Lack of Trained Specialists in Developing Countries
    • 3.4. Market Trends
      • 3.4.1. Advancement in Technology of Radiation Oncology
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Radiation Oncology, by Type, Application, Technology, End User and Region (value and price ) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Radiation Oncology (Value)
      • 5.2.1. Global Radiation Oncology by: Type (Value)
        • 5.2.1.1. External Beam Radiation Therapy
        • 5.2.1.2. Brachytherapy
        • 5.2.1.3. Systemic Beam Radiation Therapy
        • 5.2.1.4. Others
      • 5.2.2. Global Radiation Oncology by: Application (Value)
        • 5.2.2.1. Blood Cancer (Leukaemia)
        • 5.2.2.2. Breast Cancer
        • 5.2.2.3. Gastrointestinal Cancer
        • 5.2.2.4. Respiratory/Lung Cancer
        • 5.2.2.5. Skin Cancer
        • 5.2.2.6. Other
      • 5.2.3. Global Radiation Oncology by: Technology (Value)
        • 5.2.3.1. Image-Guided Radiation Therapy (IGRT)
        • 5.2.3.2. Intensity-Modulated Radiation Therapy (IMRT)
        • 5.2.3.3. High Dose Rate (HDR) Brachytherapy
        • 5.2.3.4. Low Dose Rate (LDR) Brachytherapy
        • 5.2.3.5. Others
      • 5.2.4. Global Radiation Oncology by: End User (Value)
        • 5.2.4.1. Hospitals
        • 5.2.4.2. Clinics
        • 5.2.4.3. Others
      • 5.2.5. Global Radiation Oncology Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Radiation Oncology (Price)
      • 5.3.1. Global Radiation Oncology by: Type (Price)
  • 6. Radiation Oncology: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Varian Medical Systems (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Elekta AB (Sweden)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Accuray Incorporated (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Ion Beam Applications SA (Belgium)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. C.R. Bard, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Isoray Medical, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Mevion Medical Systems, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Nordian Inc. (Canada)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. NTP Radioisotopes (South Africa)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. EviCore (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Radiation Oncology Sale, by Type, Application, Technology, End User and Region (value and price ) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Radiation Oncology (Value)
      • 7.2.1. Global Radiation Oncology by: Type (Value)
        • 7.2.1.1. External Beam Radiation Therapy
        • 7.2.1.2. Brachytherapy
        • 7.2.1.3. Systemic Beam Radiation Therapy
        • 7.2.1.4. Others
      • 7.2.2. Global Radiation Oncology by: Application (Value)
        • 7.2.2.1. Blood Cancer (Leukaemia)
        • 7.2.2.2. Breast Cancer
        • 7.2.2.3. Gastrointestinal Cancer
        • 7.2.2.4. Respiratory/Lung Cancer
        • 7.2.2.5. Skin Cancer
        • 7.2.2.6. Other
      • 7.2.3. Global Radiation Oncology by: Technology (Value)
        • 7.2.3.1. Image-Guided Radiation Therapy (IGRT)
        • 7.2.3.2. Intensity-Modulated Radiation Therapy (IMRT)
        • 7.2.3.3. High Dose Rate (HDR) Brachytherapy
        • 7.2.3.4. Low Dose Rate (LDR) Brachytherapy
        • 7.2.3.5. Others
      • 7.2.4. Global Radiation Oncology by: End User (Value)
        • 7.2.4.1. Hospitals
        • 7.2.4.2. Clinics
        • 7.2.4.3. Others
      • 7.2.5. Global Radiation Oncology Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Radiation Oncology (Price)
      • 7.3.1. Global Radiation Oncology by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Radiation Oncology: by Type(USD Million)
  • Table 2. Radiation Oncology External Beam Radiation Therapy , by Region USD Million (2013-2018)
  • Table 3. Radiation Oncology Brachytherapy , by Region USD Million (2013-2018)
  • Table 4. Radiation Oncology Systemic Beam Radiation Therapy , by Region USD Million (2013-2018)
  • Table 5. Radiation Oncology Others , by Region USD Million (2013-2018)
  • Table 6. Radiation Oncology: by Application(USD Million)
  • Table 7. Radiation Oncology Blood Cancer (Leukaemia) , by Region USD Million (2013-2018)
  • Table 8. Radiation Oncology Breast Cancer , by Region USD Million (2013-2018)
  • Table 9. Radiation Oncology Gastrointestinal Cancer , by Region USD Million (2013-2018)
  • Table 10. Radiation Oncology Respiratory/Lung Cancer , by Region USD Million (2013-2018)
  • Table 11. Radiation Oncology Skin Cancer , by Region USD Million (2013-2018)
  • Table 12. Radiation Oncology Other , by Region USD Million (2013-2018)
  • Table 13. Radiation Oncology: by Technology(USD Million)
  • Table 14. Radiation Oncology Image-Guided Radiation Therapy (IGRT) , by Region USD Million (2013-2018)
  • Table 15. Radiation Oncology Intensity-Modulated Radiation Therapy (IMRT) , by Region USD Million (2013-2018)
  • Table 16. Radiation Oncology High Dose Rate (HDR) Brachytherapy , by Region USD Million (2013-2018)
  • Table 17. Radiation Oncology Low Dose Rate (LDR) Brachytherapy , by Region USD Million (2013-2018)
  • Table 18. Radiation Oncology Others , by Region USD Million (2013-2018)
  • Table 19. Radiation Oncology: by End User(USD Million)
  • Table 20. Radiation Oncology Hospitals , by Region USD Million (2013-2018)
  • Table 21. Radiation Oncology Clinics , by Region USD Million (2013-2018)
  • Table 22. Radiation Oncology Others , by Region USD Million (2013-2018)
  • Table 23. South America Radiation Oncology, by Country USD Million (2013-2018)
  • Table 24. South America Radiation Oncology, by Type USD Million (2013-2018)
  • Table 25. South America Radiation Oncology, by Application USD Million (2013-2018)
  • Table 26. South America Radiation Oncology, by Technology USD Million (2013-2018)
  • Table 27. South America Radiation Oncology, by End User USD Million (2013-2018)
  • Table 28. Brazil Radiation Oncology, by Type USD Million (2013-2018)
  • Table 29. Brazil Radiation Oncology, by Application USD Million (2013-2018)
  • Table 30. Brazil Radiation Oncology, by Technology USD Million (2013-2018)
  • Table 31. Brazil Radiation Oncology, by End User USD Million (2013-2018)
  • Table 32. Argentina Radiation Oncology, by Type USD Million (2013-2018)
  • Table 33. Argentina Radiation Oncology, by Application USD Million (2013-2018)
  • Table 34. Argentina Radiation Oncology, by Technology USD Million (2013-2018)
  • Table 35. Argentina Radiation Oncology, by End User USD Million (2013-2018)
  • Table 36. Rest of South America Radiation Oncology, by Type USD Million (2013-2018)
  • Table 37. Rest of South America Radiation Oncology, by Application USD Million (2013-2018)
  • Table 38. Rest of South America Radiation Oncology, by Technology USD Million (2013-2018)
  • Table 39. Rest of South America Radiation Oncology, by End User USD Million (2013-2018)
  • Table 40. Asia Pacific Radiation Oncology, by Country USD Million (2013-2018)
  • Table 41. Asia Pacific Radiation Oncology, by Type USD Million (2013-2018)
  • Table 42. Asia Pacific Radiation Oncology, by Application USD Million (2013-2018)
  • Table 43. Asia Pacific Radiation Oncology, by Technology USD Million (2013-2018)
  • Table 44. Asia Pacific Radiation Oncology, by End User USD Million (2013-2018)
  • Table 45. China Radiation Oncology, by Type USD Million (2013-2018)
  • Table 46. China Radiation Oncology, by Application USD Million (2013-2018)
  • Table 47. China Radiation Oncology, by Technology USD Million (2013-2018)
  • Table 48. China Radiation Oncology, by End User USD Million (2013-2018)
  • Table 49. Japan Radiation Oncology, by Type USD Million (2013-2018)
  • Table 50. Japan Radiation Oncology, by Application USD Million (2013-2018)
  • Table 51. Japan Radiation Oncology, by Technology USD Million (2013-2018)
  • Table 52. Japan Radiation Oncology, by End User USD Million (2013-2018)
  • Table 53. India Radiation Oncology, by Type USD Million (2013-2018)
  • Table 54. India Radiation Oncology, by Application USD Million (2013-2018)
  • Table 55. India Radiation Oncology, by Technology USD Million (2013-2018)
  • Table 56. India Radiation Oncology, by End User USD Million (2013-2018)
  • Table 57. South Korea Radiation Oncology, by Type USD Million (2013-2018)
  • Table 58. South Korea Radiation Oncology, by Application USD Million (2013-2018)
  • Table 59. South Korea Radiation Oncology, by Technology USD Million (2013-2018)
  • Table 60. South Korea Radiation Oncology, by End User USD Million (2013-2018)
  • Table 61. Taiwan Radiation Oncology, by Type USD Million (2013-2018)
  • Table 62. Taiwan Radiation Oncology, by Application USD Million (2013-2018)
  • Table 63. Taiwan Radiation Oncology, by Technology USD Million (2013-2018)
  • Table 64. Taiwan Radiation Oncology, by End User USD Million (2013-2018)
  • Table 65. Australia Radiation Oncology, by Type USD Million (2013-2018)
  • Table 66. Australia Radiation Oncology, by Application USD Million (2013-2018)
  • Table 67. Australia Radiation Oncology, by Technology USD Million (2013-2018)
  • Table 68. Australia Radiation Oncology, by End User USD Million (2013-2018)
  • Table 69. Rest of Asia-Pacific Radiation Oncology, by Type USD Million (2013-2018)
  • Table 70. Rest of Asia-Pacific Radiation Oncology, by Application USD Million (2013-2018)
  • Table 71. Rest of Asia-Pacific Radiation Oncology, by Technology USD Million (2013-2018)
  • Table 72. Rest of Asia-Pacific Radiation Oncology, by End User USD Million (2013-2018)
  • Table 73. Europe Radiation Oncology, by Country USD Million (2013-2018)
  • Table 74. Europe Radiation Oncology, by Type USD Million (2013-2018)
  • Table 75. Europe Radiation Oncology, by Application USD Million (2013-2018)
  • Table 76. Europe Radiation Oncology, by Technology USD Million (2013-2018)
  • Table 77. Europe Radiation Oncology, by End User USD Million (2013-2018)
  • Table 78. Germany Radiation Oncology, by Type USD Million (2013-2018)
  • Table 79. Germany Radiation Oncology, by Application USD Million (2013-2018)
  • Table 80. Germany Radiation Oncology, by Technology USD Million (2013-2018)
  • Table 81. Germany Radiation Oncology, by End User USD Million (2013-2018)
  • Table 82. France Radiation Oncology, by Type USD Million (2013-2018)
  • Table 83. France Radiation Oncology, by Application USD Million (2013-2018)
  • Table 84. France Radiation Oncology, by Technology USD Million (2013-2018)
  • Table 85. France Radiation Oncology, by End User USD Million (2013-2018)
  • Table 86. Italy Radiation Oncology, by Type USD Million (2013-2018)
  • Table 87. Italy Radiation Oncology, by Application USD Million (2013-2018)
  • Table 88. Italy Radiation Oncology, by Technology USD Million (2013-2018)
  • Table 89. Italy Radiation Oncology, by End User USD Million (2013-2018)
  • Table 90. United Kingdom Radiation Oncology, by Type USD Million (2013-2018)
  • Table 91. United Kingdom Radiation Oncology, by Application USD Million (2013-2018)
  • Table 92. United Kingdom Radiation Oncology, by Technology USD Million (2013-2018)
  • Table 93. United Kingdom Radiation Oncology, by End User USD Million (2013-2018)
  • Table 94. Netherlands Radiation Oncology, by Type USD Million (2013-2018)
  • Table 95. Netherlands Radiation Oncology, by Application USD Million (2013-2018)
  • Table 96. Netherlands Radiation Oncology, by Technology USD Million (2013-2018)
  • Table 97. Netherlands Radiation Oncology, by End User USD Million (2013-2018)
  • Table 98. Rest of Europe Radiation Oncology, by Type USD Million (2013-2018)
  • Table 99. Rest of Europe Radiation Oncology, by Application USD Million (2013-2018)
  • Table 100. Rest of Europe Radiation Oncology, by Technology USD Million (2013-2018)
  • Table 101. Rest of Europe Radiation Oncology, by End User USD Million (2013-2018)
  • Table 102. MEA Radiation Oncology, by Country USD Million (2013-2018)
  • Table 103. MEA Radiation Oncology, by Type USD Million (2013-2018)
  • Table 104. MEA Radiation Oncology, by Application USD Million (2013-2018)
  • Table 105. MEA Radiation Oncology, by Technology USD Million (2013-2018)
  • Table 106. MEA Radiation Oncology, by End User USD Million (2013-2018)
  • Table 107. Middle East Radiation Oncology, by Type USD Million (2013-2018)
  • Table 108. Middle East Radiation Oncology, by Application USD Million (2013-2018)
  • Table 109. Middle East Radiation Oncology, by Technology USD Million (2013-2018)
  • Table 110. Middle East Radiation Oncology, by End User USD Million (2013-2018)
  • Table 111. Africa Radiation Oncology, by Type USD Million (2013-2018)
  • Table 112. Africa Radiation Oncology, by Application USD Million (2013-2018)
  • Table 113. Africa Radiation Oncology, by Technology USD Million (2013-2018)
  • Table 114. Africa Radiation Oncology, by End User USD Million (2013-2018)
  • Table 115. North America Radiation Oncology, by Country USD Million (2013-2018)
  • Table 116. North America Radiation Oncology, by Type USD Million (2013-2018)
  • Table 117. North America Radiation Oncology, by Application USD Million (2013-2018)
  • Table 118. North America Radiation Oncology, by Technology USD Million (2013-2018)
  • Table 119. North America Radiation Oncology, by End User USD Million (2013-2018)
  • Table 120. United States Radiation Oncology, by Type USD Million (2013-2018)
  • Table 121. United States Radiation Oncology, by Application USD Million (2013-2018)
  • Table 122. United States Radiation Oncology, by Technology USD Million (2013-2018)
  • Table 123. United States Radiation Oncology, by End User USD Million (2013-2018)
  • Table 124. Canada Radiation Oncology, by Type USD Million (2013-2018)
  • Table 125. Canada Radiation Oncology, by Application USD Million (2013-2018)
  • Table 126. Canada Radiation Oncology, by Technology USD Million (2013-2018)
  • Table 127. Canada Radiation Oncology, by End User USD Million (2013-2018)
  • Table 128. Mexico Radiation Oncology, by Type USD Million (2013-2018)
  • Table 129. Mexico Radiation Oncology, by Application USD Million (2013-2018)
  • Table 130. Mexico Radiation Oncology, by Technology USD Million (2013-2018)
  • Table 131. Mexico Radiation Oncology, by End User USD Million (2013-2018)
  • Table 132. Radiation Oncology: by Type(USD/Units)
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Radiation Oncology: by Type(USD Million)
  • Table 144. Radiation Oncology External Beam Radiation Therapy , by Region USD Million (2019-2024)
  • Table 145. Radiation Oncology Brachytherapy , by Region USD Million (2019-2024)
  • Table 146. Radiation Oncology Systemic Beam Radiation Therapy , by Region USD Million (2019-2024)
  • Table 147. Radiation Oncology Others , by Region USD Million (2019-2024)
  • Table 148. Radiation Oncology: by Application(USD Million)
  • Table 149. Radiation Oncology Blood Cancer (Leukaemia) , by Region USD Million (2019-2024)
  • Table 150. Radiation Oncology Breast Cancer , by Region USD Million (2019-2024)
  • Table 151. Radiation Oncology Gastrointestinal Cancer , by Region USD Million (2019-2024)
  • Table 152. Radiation Oncology Respiratory/Lung Cancer , by Region USD Million (2019-2024)
  • Table 153. Radiation Oncology Skin Cancer , by Region USD Million (2019-2024)
  • Table 154. Radiation Oncology Other , by Region USD Million (2019-2024)
  • Table 155. Radiation Oncology: by Technology(USD Million)
  • Table 156. Radiation Oncology Image-Guided Radiation Therapy (IGRT) , by Region USD Million (2019-2024)
  • Table 157. Radiation Oncology Intensity-Modulated Radiation Therapy (IMRT) , by Region USD Million (2019-2024)
  • Table 158. Radiation Oncology High Dose Rate (HDR) Brachytherapy , by Region USD Million (2019-2024)
  • Table 159. Radiation Oncology Low Dose Rate (LDR) Brachytherapy , by Region USD Million (2019-2024)
  • Table 160. Radiation Oncology Others , by Region USD Million (2019-2024)
  • Table 161. Radiation Oncology: by End User(USD Million)
  • Table 162. Radiation Oncology Hospitals , by Region USD Million (2019-2024)
  • Table 163. Radiation Oncology Clinics , by Region USD Million (2019-2024)
  • Table 164. Radiation Oncology Others , by Region USD Million (2019-2024)
  • Table 165. South America Radiation Oncology, by Country USD Million (2019-2024)
  • Table 166. South America Radiation Oncology, by Type USD Million (2019-2024)
  • Table 167. South America Radiation Oncology, by Application USD Million (2019-2024)
  • Table 168. South America Radiation Oncology, by Technology USD Million (2019-2024)
  • Table 169. South America Radiation Oncology, by End User USD Million (2019-2024)
  • Table 170. Brazil Radiation Oncology, by Type USD Million (2019-2024)
  • Table 171. Brazil Radiation Oncology, by Application USD Million (2019-2024)
  • Table 172. Brazil Radiation Oncology, by Technology USD Million (2019-2024)
  • Table 173. Brazil Radiation Oncology, by End User USD Million (2019-2024)
  • Table 174. Argentina Radiation Oncology, by Type USD Million (2019-2024)
  • Table 175. Argentina Radiation Oncology, by Application USD Million (2019-2024)
  • Table 176. Argentina Radiation Oncology, by Technology USD Million (2019-2024)
  • Table 177. Argentina Radiation Oncology, by End User USD Million (2019-2024)
  • Table 178. Rest of South America Radiation Oncology, by Type USD Million (2019-2024)
  • Table 179. Rest of South America Radiation Oncology, by Application USD Million (2019-2024)
  • Table 180. Rest of South America Radiation Oncology, by Technology USD Million (2019-2024)
  • Table 181. Rest of South America Radiation Oncology, by End User USD Million (2019-2024)
  • Table 182. Asia Pacific Radiation Oncology, by Country USD Million (2019-2024)
  • Table 183. Asia Pacific Radiation Oncology, by Type USD Million (2019-2024)
  • Table 184. Asia Pacific Radiation Oncology, by Application USD Million (2019-2024)
  • Table 185. Asia Pacific Radiation Oncology, by Technology USD Million (2019-2024)
  • Table 186. Asia Pacific Radiation Oncology, by End User USD Million (2019-2024)
  • Table 187. China Radiation Oncology, by Type USD Million (2019-2024)
  • Table 188. China Radiation Oncology, by Application USD Million (2019-2024)
  • Table 189. China Radiation Oncology, by Technology USD Million (2019-2024)
  • Table 190. China Radiation Oncology, by End User USD Million (2019-2024)
  • Table 191. Japan Radiation Oncology, by Type USD Million (2019-2024)
  • Table 192. Japan Radiation Oncology, by Application USD Million (2019-2024)
  • Table 193. Japan Radiation Oncology, by Technology USD Million (2019-2024)
  • Table 194. Japan Radiation Oncology, by End User USD Million (2019-2024)
  • Table 195. India Radiation Oncology, by Type USD Million (2019-2024)
  • Table 196. India Radiation Oncology, by Application USD Million (2019-2024)
  • Table 197. India Radiation Oncology, by Technology USD Million (2019-2024)
  • Table 198. India Radiation Oncology, by End User USD Million (2019-2024)
  • Table 199. South Korea Radiation Oncology, by Type USD Million (2019-2024)
  • Table 200. South Korea Radiation Oncology, by Application USD Million (2019-2024)
  • Table 201. South Korea Radiation Oncology, by Technology USD Million (2019-2024)
  • Table 202. South Korea Radiation Oncology, by End User USD Million (2019-2024)
  • Table 203. Taiwan Radiation Oncology, by Type USD Million (2019-2024)
  • Table 204. Taiwan Radiation Oncology, by Application USD Million (2019-2024)
  • Table 205. Taiwan Radiation Oncology, by Technology USD Million (2019-2024)
  • Table 206. Taiwan Radiation Oncology, by End User USD Million (2019-2024)
  • Table 207. Australia Radiation Oncology, by Type USD Million (2019-2024)
  • Table 208. Australia Radiation Oncology, by Application USD Million (2019-2024)
  • Table 209. Australia Radiation Oncology, by Technology USD Million (2019-2024)
  • Table 210. Australia Radiation Oncology, by End User USD Million (2019-2024)
  • Table 211. Rest of Asia-Pacific Radiation Oncology, by Type USD Million (2019-2024)
  • Table 212. Rest of Asia-Pacific Radiation Oncology, by Application USD Million (2019-2024)
  • Table 213. Rest of Asia-Pacific Radiation Oncology, by Technology USD Million (2019-2024)
  • Table 214. Rest of Asia-Pacific Radiation Oncology, by End User USD Million (2019-2024)
  • Table 215. Europe Radiation Oncology, by Country USD Million (2019-2024)
  • Table 216. Europe Radiation Oncology, by Type USD Million (2019-2024)
  • Table 217. Europe Radiation Oncology, by Application USD Million (2019-2024)
  • Table 218. Europe Radiation Oncology, by Technology USD Million (2019-2024)
  • Table 219. Europe Radiation Oncology, by End User USD Million (2019-2024)
  • Table 220. Germany Radiation Oncology, by Type USD Million (2019-2024)
  • Table 221. Germany Radiation Oncology, by Application USD Million (2019-2024)
  • Table 222. Germany Radiation Oncology, by Technology USD Million (2019-2024)
  • Table 223. Germany Radiation Oncology, by End User USD Million (2019-2024)
  • Table 224. France Radiation Oncology, by Type USD Million (2019-2024)
  • Table 225. France Radiation Oncology, by Application USD Million (2019-2024)
  • Table 226. France Radiation Oncology, by Technology USD Million (2019-2024)
  • Table 227. France Radiation Oncology, by End User USD Million (2019-2024)
  • Table 228. Italy Radiation Oncology, by Type USD Million (2019-2024)
  • Table 229. Italy Radiation Oncology, by Application USD Million (2019-2024)
  • Table 230. Italy Radiation Oncology, by Technology USD Million (2019-2024)
  • Table 231. Italy Radiation Oncology, by End User USD Million (2019-2024)
  • Table 232. United Kingdom Radiation Oncology, by Type USD Million (2019-2024)
  • Table 233. United Kingdom Radiation Oncology, by Application USD Million (2019-2024)
  • Table 234. United Kingdom Radiation Oncology, by Technology USD Million (2019-2024)
  • Table 235. United Kingdom Radiation Oncology, by End User USD Million (2019-2024)
  • Table 236. Netherlands Radiation Oncology, by Type USD Million (2019-2024)
  • Table 237. Netherlands Radiation Oncology, by Application USD Million (2019-2024)
  • Table 238. Netherlands Radiation Oncology, by Technology USD Million (2019-2024)
  • Table 239. Netherlands Radiation Oncology, by End User USD Million (2019-2024)
  • Table 240. Rest of Europe Radiation Oncology, by Type USD Million (2019-2024)
  • Table 241. Rest of Europe Radiation Oncology, by Application USD Million (2019-2024)
  • Table 242. Rest of Europe Radiation Oncology, by Technology USD Million (2019-2024)
  • Table 243. Rest of Europe Radiation Oncology, by End User USD Million (2019-2024)
  • Table 244. MEA Radiation Oncology, by Country USD Million (2019-2024)
  • Table 245. MEA Radiation Oncology, by Type USD Million (2019-2024)
  • Table 246. MEA Radiation Oncology, by Application USD Million (2019-2024)
  • Table 247. MEA Radiation Oncology, by Technology USD Million (2019-2024)
  • Table 248. MEA Radiation Oncology, by End User USD Million (2019-2024)
  • Table 249. Middle East Radiation Oncology, by Type USD Million (2019-2024)
  • Table 250. Middle East Radiation Oncology, by Application USD Million (2019-2024)
  • Table 251. Middle East Radiation Oncology, by Technology USD Million (2019-2024)
  • Table 252. Middle East Radiation Oncology, by End User USD Million (2019-2024)
  • Table 253. Africa Radiation Oncology, by Type USD Million (2019-2024)
  • Table 254. Africa Radiation Oncology, by Application USD Million (2019-2024)
  • Table 255. Africa Radiation Oncology, by Technology USD Million (2019-2024)
  • Table 256. Africa Radiation Oncology, by End User USD Million (2019-2024)
  • Table 257. North America Radiation Oncology, by Country USD Million (2019-2024)
  • Table 258. North America Radiation Oncology, by Type USD Million (2019-2024)
  • Table 259. North America Radiation Oncology, by Application USD Million (2019-2024)
  • Table 260. North America Radiation Oncology, by Technology USD Million (2019-2024)
  • Table 261. North America Radiation Oncology, by End User USD Million (2019-2024)
  • Table 262. United States Radiation Oncology, by Type USD Million (2019-2024)
  • Table 263. United States Radiation Oncology, by Application USD Million (2019-2024)
  • Table 264. United States Radiation Oncology, by Technology USD Million (2019-2024)
  • Table 265. United States Radiation Oncology, by End User USD Million (2019-2024)
  • Table 266. Canada Radiation Oncology, by Type USD Million (2019-2024)
  • Table 267. Canada Radiation Oncology, by Application USD Million (2019-2024)
  • Table 268. Canada Radiation Oncology, by Technology USD Million (2019-2024)
  • Table 269. Canada Radiation Oncology, by End User USD Million (2019-2024)
  • Table 270. Mexico Radiation Oncology, by Type USD Million (2019-2024)
  • Table 271. Mexico Radiation Oncology, by Application USD Million (2019-2024)
  • Table 272. Mexico Radiation Oncology, by Technology USD Million (2019-2024)
  • Table 273. Mexico Radiation Oncology, by End User USD Million (2019-2024)
  • Table 274. Radiation Oncology: by Type(USD/Units)
  • Table 275. Research Programs/Design for This Report
  • Table 276. Key Data Information from Secondary Sources
  • Table 277. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Radiation Oncology: by Type USD Million (2013-2018)
  • Figure 5. Global Radiation Oncology: by Application USD Million (2013-2018)
  • Figure 6. Global Radiation Oncology: by Technology USD Million (2013-2018)
  • Figure 7. Global Radiation Oncology: by End User USD Million (2013-2018)
  • Figure 8. South America Radiation Oncology Share (%), by Country
  • Figure 9. Asia Pacific Radiation Oncology Share (%), by Country
  • Figure 10. Europe Radiation Oncology Share (%), by Country
  • Figure 11. MEA Radiation Oncology Share (%), by Country
  • Figure 12. North America Radiation Oncology Share (%), by Country
  • Figure 13. Global Radiation Oncology: by Type USD/Units (2013-2018)
  • Figure 14. Global Radiation Oncology share by Players 2018 (%)
  • Figure 15. Global Radiation Oncology share by Players (Top 3) 2018(%)
  • Figure 16. Global Radiation Oncology share by Players (Top 5) 2018(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Varian Medical Systems (United States) Revenue, Net Income and Gross profit
  • Figure 19. Varian Medical Systems (United States) Revenue: by Geography 2018
  • Figure 20. Elekta AB (Sweden) Revenue, Net Income and Gross profit
  • Figure 21. Elekta AB (Sweden) Revenue: by Geography 2018
  • Figure 22. Accuray Incorporated (United States) Revenue, Net Income and Gross profit
  • Figure 23. Accuray Incorporated (United States) Revenue: by Geography 2018
  • Figure 24. Ion Beam Applications SA (Belgium) Revenue, Net Income and Gross profit
  • Figure 25. Ion Beam Applications SA (Belgium) Revenue: by Geography 2018
  • Figure 26. C.R. Bard, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 27. C.R. Bard, Inc. (United States) Revenue: by Geography 2018
  • Figure 28. Isoray Medical, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 29. Isoray Medical, Inc. (United States) Revenue: by Geography 2018
  • Figure 30. Mevion Medical Systems, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 31. Mevion Medical Systems, Inc. (United States) Revenue: by Geography 2018
  • Figure 32. Nordian Inc. (Canada) Revenue, Net Income and Gross profit
  • Figure 33. Nordian Inc. (Canada) Revenue: by Geography 2018
  • Figure 34. NTP Radioisotopes (South Africa) Revenue, Net Income and Gross profit
  • Figure 35. NTP Radioisotopes (South Africa) Revenue: by Geography 2018
  • Figure 36. EviCore (United States) Revenue, Net Income and Gross profit
  • Figure 37. EviCore (United States) Revenue: by Geography 2018
  • Figure 38. Global Radiation Oncology: by Type USD Million (2019-2024)
  • Figure 39. Global Radiation Oncology: by Application USD Million (2019-2024)
  • Figure 40. Global Radiation Oncology: by Technology USD Million (2019-2024)
  • Figure 41. Global Radiation Oncology: by End User USD Million (2019-2024)
  • Figure 42. South America Radiation Oncology Share (%), by Country
  • Figure 43. Asia Pacific Radiation Oncology Share (%), by Country
  • Figure 44. Europe Radiation Oncology Share (%), by Country
  • Figure 45. MEA Radiation Oncology Share (%), by Country
  • Figure 46. North America Radiation Oncology Share (%), by Country
  • Figure 47. Global Radiation Oncology: by Type USD/Units (2019-2024)
Some of the key companies/manufacturers profiled in the report
  • Varian Medical Systems (United States)
  • Elekta AB (Sweden)
  • Accuray Incorporated (United States)
  • Ion Beam Applications SA (Belgium)
  • C.R. Bard, Inc. (United States)
  • Isoray Medical, Inc. (United States)
  • Mevion Medical Systems, Inc. (United States)
  • Nordian Inc. (Canada)
  • NTP Radioisotopes (South Africa)
  • eviCore (United States)
Additional players considered in the study are as follows:
CIVCO Radiotherapy (United States) , Bionix Radiation Therapy (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation